135 related items for PubMed ID: 2698488
1. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
Klinger M, Szewczyk Z.
Przegl Lek; 1989; 46(12):816-21. PubMed ID: 2698488
[No Abstract] [Full Text] [Related]
2. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[Abstract] [Full Text] [Related]
3. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J.
Klin Wochenschr; 1988 Oct 17; 66(20):1019-23. PubMed ID: 3148785
[Abstract] [Full Text] [Related]
4. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
Klinger M, Szewczyk Z.
Przegl Lek; 1989 Oct 17; 46(10):744-9. PubMed ID: 2687950
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P, Frey FJ.
Ther Umsch; 1993 Feb 17; 50(2):119-29. PubMed ID: 8456416
[Abstract] [Full Text] [Related]
6. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
Proc Eur Dial Transplant Assoc; 1983 Feb 17; 19():717-23. PubMed ID: 6348763
[Abstract] [Full Text] [Related]
7. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
[Abstract] [Full Text] [Related]
8. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
Naumovic R, Furuncic D, Jovanovic D, Stosovic M, Basta-Jovanovic G, Lezaic V.
Biomed Pharmacother; 2010 Nov 01; 64(9):633-8. PubMed ID: 20888177
[Abstract] [Full Text] [Related]
9. Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study.
Yuan J, Fang W, Zhang W, Ni Z, Qian J.
Nephrology (Carlton); 2011 May 01; 16(4):440-5. PubMed ID: 21091923
[Abstract] [Full Text] [Related]
10. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA, Rovin BH, Agarwal AK, Spetie DN.
Am J Kidney Dis; 2005 Apr 01; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
11. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL, Shkerina LI, Shilov EM.
Klin Med (Mosk); 2005 Apr 01; 83(10):48-50. PubMed ID: 16320847
[Abstract] [Full Text] [Related]
12. Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis.
Cattran DC.
Clin Nephrol; 1991 Apr 01; 35 Suppl 1():S43-7. PubMed ID: 1860267
[Abstract] [Full Text] [Related]
13. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
J Nephrol; 2008 Apr 01; 21(4):584-91. PubMed ID: 18651550
[Abstract] [Full Text] [Related]
14. Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).
Mohácsi G, Magori A, Sonkodi S.
Int Urol Nephrol; 1988 Apr 01; 20(3):315-25. PubMed ID: 3403200
[Abstract] [Full Text] [Related]
15. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa, Biriukova LS, Makurov AI.
Ter Arkh; 1992 Apr 01; 64(8):47-50. PubMed ID: 1440396
[No Abstract] [Full Text] [Related]
16. Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone.
Tietjen DP.
Clin Nephrol; 1990 Mar 01; 33(3):152. PubMed ID: 2323113
[No Abstract] [Full Text] [Related]
17. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
Riabov SI, Stavskaia VV, Sheveleva LA.
Ter Arkh; 1990 Mar 01; 62(9):91-7. PubMed ID: 2281418
[Abstract] [Full Text] [Related]
18. [The therapy of mesangiocapillary glomerulonephritis].
Ratner MIa, Fedorova ND, Biriukova LS, Makurov AI.
Ter Arkh; 1995 Mar 01; 67(8):10-2. PubMed ID: 7482319
[Abstract] [Full Text] [Related]
19. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug 01; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
20. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
Am J Kidney Dis; 2006 Feb 01; 47(2):233-40. PubMed ID: 16431252
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
